News Aclaris Therapeutics, Inc.

Equities

ACRS

US00461U1051

Real-time Estimate Cboe BZX Other stock markets 10:39:53 2024-04-25 am EDT			5-day change	1st Jan Change
1.165 ^USD	-0.43%		-4.88%	+11.43%

Mar. 19	Aclaris Therapeutics, Inc. Announces Board Resignations	CI
Feb. 27	Aclaris Therapeutics, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	CI

Summary

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

FLARE THERAPEUTICS APPOINTS DOUGLAS MANION, M.D., FRCP AS CHIEF EXECUTIVE OFFICER	Apr. 24	AQ
Aclaris Therapeutics, Inc. Announces Board Resignations	Mar. 19	CI
Aclaris: Q4 Earnings Snapshot	Feb. 27	AQ
Aclaris Therapeutics, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	Feb. 27	CI
Aclaris Therapeutics, Inc. Announces Intangible Asset Impairment for the Three Months Ended December 31, 2023	Feb. 27	CI
Earnings Flash (ACRS) ACLARIS THERAPEUTICS Posts Q4 Revenue $17.6M	Feb. 27	MT
Aclaris Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Provides a Corporate Update	Feb. 27	AQ
Aclaris Therapeutics, Inc. Reports Earnings Results for the Fourth Quarter Ended December 31, 2023	Feb. 27	CI
North American Morning Briefing : Stock Futures -2-	Feb. 21	DJ
Aclaris Therapeutics, Inc. Announces Termination of Employment of Gail Cawkwell as Chief Medical Officer	Feb. 05	CI
North American Morning Briefing : Stock Futures -2-	Jan. 23	DJ
HC Wainwright Downgrades Aclaris Therapeutics to Neutral From Buy	Jan. 22	MT
Sector Update: Health Care Stocks Weaker Late Afternoon	Jan. 16	MT
Sector Update: Health Care Stocks Softer Tuesday Afternoon	Jan. 16	MT
Aclaris Therapeutics Shares Rise; Strategic Review Announced, CEO Manion to Step Down	Jan. 16	MT
Aclaris Therapeutics Conducts Strategic Review of Business	Jan. 16	CI
Aclaris Therapeutics Announces Leadership Changes and Strategic Business Review	Jan. 16	AQ
Aclaris Therapeutics, Inc. Announces Executive Changes	Jan. 16	CI
Aclaris Therapeutics, Inc. Announces Chief Executive Officer Changes	Jan. 16	CI
North American Morning Briefing : Stock Futures -2-	Jan. 12	DJ

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

News Aclaris Therapeutics, Inc.

Equities

ACRS

US00461U1051

Summary

Filters